| NCT04271735 |
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis |
https://ClinicalTrials.gov/show/NCT04271735 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-01-31 |
| NCT03382756 |
A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 |
https://ClinicalTrials.gov/show/NCT03382756 |
Completed |
Chong Kun Dang Pharmaceutical |
2017-11-02 |
| NCT03370848 |
Effects of Psyllium on Niacin Tolerability |
https://ClinicalTrials.gov/show/NCT03370848 |
Completed |
VA Greater Los Angeles Healthcare System |
2011-07-31 |
| NCT03367663 |
The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System. |
https://ClinicalTrials.gov/show/NCT03367663 |
Completed |
Rambam Health Care Campus |
2018-07-09 |
| NCT03418974 |
Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03418974 |
Active, not recruiting |
Fudan University |
2021-12-31 |
| NCT03338426 |
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03338426 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2019-04-22 |
| NCT03307031 |
The Influence of Pilates Exercises Training Volume on Metabolic Outcomes in Dyslipidemic Women. |
https://ClinicalTrials.gov/show/NCT03307031 |
Completed |
Federal University of Rio Grande do Sul |
2017-07-28 |
| NCT03295448 |
Fatty Acid Biomarkers of Carbohydrate Intake |
https://ClinicalTrials.gov/show/NCT03295448 |
Completed |
Uppsala University |
2018-06-01 |
| NCT03294044 |
The Effectiveness of Smart Health Management Program for Patients With Chronic Illness |
https://ClinicalTrials.gov/show/NCT03294044 |
Completed |
Seoul National University Hospital |
2018-03-26 |
| NCT03291548 |
Quinoa Biscuit & CVD Risk Trial |
https://ClinicalTrials.gov/show/NCT03291548 |
Completed |
University of Ulster |
2017-06-19 |
| NCT03284918 |
Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester |
https://ClinicalTrials.gov/show/NCT03284918 |
Completed |
Raisio Group |
2016-03-31 |
| NCT03267329 |
Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension |
https://ClinicalTrials.gov/show/NCT03267329 |
Recruiting |
Yuhan Corporation |
2020-08-31 |
| NCT03254446 |
Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension |
https://ClinicalTrials.gov/show/NCT03254446 |
Recruiting |
Torrent Pharmaceuticals Limited |
2020-04-30 |
| NCT03251690 |
Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression |
https://ClinicalTrials.gov/show/NCT03251690 |
Completed |
Mahidol University |
2018-04-30 |
| NCT03247140 |
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers |
https://ClinicalTrials.gov/show/NCT03247140 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2017-08-07 |
| NCT03241121 |
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT03241121 |
Active, not recruiting |
University of Lausanne Hospitals |
2020-03-31 |
| NCT03235362 |
A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 |
https://ClinicalTrials.gov/show/NCT03235362 |
Completed |
Yuhan Corporation |
2017-09-19 |
| NCT03221816 |
Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial |
https://ClinicalTrials.gov/show/NCT03221816 |
Completed |
Casa de Saúde santa Marcelina |
2010-01-31 |
| NCT03210649 |
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 |
https://ClinicalTrials.gov/show/NCT03210649 |
Completed |
Chong Kun Dang Pharmaceutical |
2017-04-24 |
| NCT03210532 |
Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03210532 |
Completed |
Daewon Pharmaceutical Co., Ltd. |
2017-09-30 |
| NCT03207945 |
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) |
https://ClinicalTrials.gov/show/NCT03207945 |
Recruiting |
University of California, San Francisco |
2021-11-30 |
| NCT03203915 |
Metabolic Response to Chardonnay Grape Marc Powder |
https://ClinicalTrials.gov/show/NCT03203915 |
Completed |
USDA, Western Human Nutrition Research Center |
2019-06-28 |
| NCT03175835 |
Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT03175835 |
Completed |
Chong Kun Dang Pharmaceutical |
2017-06-19 |
| NCT03173495 |
Effects of Exercise on Fructose-induced Postprandial Lipemia |
https://ClinicalTrials.gov/show/NCT03173495 |
Completed |
Federal University of Rio Grande do Sul |
2016-12-15 |
| NCT03170752 |
Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) |
https://ClinicalTrials.gov/show/NCT03170752 |
Completed |
Memorial University of Newfoundland |
2018-09-29 |
| NCT03167996 |
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology |
https://ClinicalTrials.gov/show/NCT03167996 |
Completed |
Stanford University |
2018-03-01 |
| NCT03133975 |
Vitamin D Supplementation for Treatment of Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03133975 |
Recruiting |
Mansoura University |
2018-12-31 |
| NCT03109834 |
Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women |
https://ClinicalTrials.gov/show/NCT03109834 |
Completed |
Bonn Education Association for Dietetics r.A., Cologne, Germany |
2007-03-28 |
| NCT03104543 |
Communicating Health Information and Improving Coordination With Primary Care |
https://ClinicalTrials.gov/show/NCT03104543 |
Enrolling by invitation |
Fred Hutchinson Cancer Research Center |
2022-03-01 |
| NCT03088254 |
Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin |
https://ClinicalTrials.gov/show/NCT03088254 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2017-07-31 |
| NCT03080935 |
Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries |
https://ClinicalTrials.gov/show/NCT03080935 |
Active, not recruiting |
Amgen |
2022-12-04 |
| NCT03071692 |
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) |
https://ClinicalTrials.gov/show/NCT03071692 |
Active, not recruiting |
Kowa Research Institute, Inc. |
2022-04-30 |
| NCT03068078 |
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03068078 |
Recruiting |
Odense University Hospital |
2019-12-31 |
| NCT03027336 |
Efficacy and Tolerability of the Nutraceutical Formulation Coleosoma in Dyslipidemic Subjects |
https://ClinicalTrials.gov/show/NCT03027336 |
Completed |
Azienda Ospedaliero-Universitaria di Parma |
2016-08-31 |
| NCT03026933 |
Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled |
https://ClinicalTrials.gov/show/NCT03026933 |
Completed |
Kuhnil Pharmaceutical Co., Ltd. |
2016-03-31 |
| NCT03025451 |
Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database |
https://ClinicalTrials.gov/show/NCT03025451 |
Completed |
Ohio University |
2015-12-31 |
| NCT03021889 |
Nutritional Therapy Improves Dyslipidemia in HIV Infected Teenagers With Antiretroviral Treatment |
https://ClinicalTrials.gov/show/NCT03021889 |
Completed |
Hospital de Clinicas de Porto Alegre |
2015-11-30 |
| NCT03019263 |
Berberine, Chlorogenic Acid and Tocotrienols in Menopause-associated Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03019263 |
Completed |
IRCCS Policlinico S. Matteo |
2018-01-12 |
| NCT02991534 |
Cardiovascular Risk Screening and Risk Reduction in Women Vets |
https://ClinicalTrials.gov/show/NCT02991534 |
Recruiting |
VA Office of Research and Development |
2020-08-31 |
| NCT02990260 |
Effect of Saccharomyces Cerevisiae in LDL Cholesterol |
https://ClinicalTrials.gov/show/NCT02990260 |
Completed |
Lesaffre International |
2017-11-30 |
| NCT02982408 |
Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02982408 |
Completed |
Rigshospitalet, Denmark |
2019-03-31 |
| NCT02977884 |
Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation Project |
https://ClinicalTrials.gov/show/NCT02977884 |
Recruiting |
Ohio University |
2020-11-30 |
| NCT02977065 |
To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors |
https://ClinicalTrials.gov/show/NCT02977065 |
Completed |
Chong Kun Dang Pharmaceutical |
2017-12-30 |
| NCT02959762 |
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K ‘n’ Kids Study II) |
https://ClinicalTrials.gov/show/NCT02959762 |
Active, not recruiting |
Augusta University |
2020-12-01 |
| NCT02956590 |
Dyslipidemia of Obesity Intervention in Teens |
https://ClinicalTrials.gov/show/NCT02956590 |
Recruiting |
HealthCore-NERI |
2024-04-30 |
| NCT02944383 |
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia |
https://ClinicalTrials.gov/show/NCT02944383 |
Completed |
NeuroBo Pharmaceuticals Inc. |
2018-01-11 |
| NCT02938091 |
Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose |
https://ClinicalTrials.gov/show/NCT02938091 |
Completed |
Tufts University |
2012-07-31 |
| NCT02933658 |
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02933658 |
Completed |
Daewon Pharmaceutical Co., Ltd. |
2015-11-30 |
| NCT02900612 |
Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women. |
https://ClinicalTrials.gov/show/NCT02900612 |
Completed |
Hospital de Clinicas de Porto Alegre |
2016-03-31 |
| NCT02899455 |
Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02899455 |
Completed |
Hanmi Pharmaceutical Company Limited |
2016-06-30 |
| NCT02881658 |
The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C |
https://ClinicalTrials.gov/show/NCT02881658 |
Completed |
The University of Hong Kong |
2017-02-01 |
| NCT02867813 |
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension |
https://ClinicalTrials.gov/show/NCT02867813 |
Active, not recruiting |
Amgen |
2021-09-29 |
| NCT02835651 |
Saturated Fatty Acids and HDL Metabolism |
https://ClinicalTrials.gov/show/NCT02835651 |
Completed |
Maastricht University Medical Center |
2017-07-01 |
| NCT02837367 |
Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People |
https://ClinicalTrials.gov/show/NCT02837367 |
Recruiting |
University of Medicine and Pharmacy “Victor Babes” Timisoara |
2019-09-30 |
| NCT02835287 |
Diabetes Complication Control in Community Clinics (D4C) Trial |
https://ClinicalTrials.gov/show/NCT02835287 |
Active, not recruiting |
Tulane University |
2021-06-30 |
| NCT02827903 |
Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02827903 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2017-11-21 |
| NCT02781675 |
The Mediterranean Full-Fat Dairy Study |
https://ClinicalTrials.gov/show/NCT02781675 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2018-06-30 |
| NCT02772900 |
Aging, Nitrate, Endothelial Function and Muscle Oxygenation |
https://ClinicalTrials.gov/show/NCT02772900 |
Completed |
Universidade Federal do Rio de Janeiro |
2015-11-30 |
| NCT02753504 |
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 |
https://ClinicalTrials.gov/show/NCT02753504 |
Completed |
Chong Kun Dang Pharmaceutical |
2016-07-31 |
| NCT02739984 |
Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02739984 |
Completed |
Amgen |
2017-08-03 |
| NCT02730559 |
Motivational Interviewing With Dyslipidemic Adolescents Together With a Parent Versus With Adolescents Alone: A Mixed Methods Clinical Trial |
https://ClinicalTrials.gov/show/NCT02730559 |
Completed |
The Hospital for Sick Children |
2014-06-30 |
| NCT02729025 |
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) |
https://ClinicalTrials.gov/show/NCT02729025 |
Completed |
Amgen |
2018-04-05 |
| NCT02727036 |
Effect of Pumpkin Seed Oil or Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT02727036 |
Completed |
Texas Woman’s University |
2017-06-16 |
| NCT02726555 |
The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin |
https://ClinicalTrials.gov/show/NCT02726555 |
Recruiting |
Wenzhou Medical University |
2019-05-31 |
| NCT02726100 |
SMARTHealth Diabetes in China Using Lay Family Health Promoters |
https://ClinicalTrials.gov/show/NCT02726100 |
Active, not recruiting |
The George Institute for Global Health, China |
2019-12-31 |
| NCT02714569 |
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02714569 |
Completed |
Eli Lilly and Company |
2017-02-28 |
| NCT02676830 |
Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312 |
https://ClinicalTrials.gov/show/NCT02676830 |
Completed |
Kowa Research Institute, Inc. |
2015-02-28 |
| NCT02662569 |
Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02662569 |
Completed |
Amgen |
2017-12-06 |
| NCT02651753 |
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 |
https://ClinicalTrials.gov/show/NCT02651753 |
Completed |
Chong Kun Dang Pharmaceutical |
2016-03-31 |
| NCT02644109 |
Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols |
https://ClinicalTrials.gov/show/NCT02644109 |
Completed |
University of Chile |
2016-03-31 |
| NCT02642159 |
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) |
https://ClinicalTrials.gov/show/NCT02642159 |
Completed |
Sanofi |
2017-03-22 |
| NCT02637115 |
Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT02637115 |
Completed |
Université Catholique de Louvain |
2018-02-20 |
| NCT02628990 |
Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks |
https://ClinicalTrials.gov/show/NCT02628990 |
Completed |
Raisio Group |
2005-08-31 |
| NCT02609243 |
Diabetes Nutrition Algorithm - Prediabetes |
https://ClinicalTrials.gov/show/NCT02609243 |
Recruiting |
German Institute of Human Nutrition |
2020-12-31 |
| NCT02586129 |
Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes |
https://ClinicalTrials.gov/show/NCT02586129 |
Completed |
Yuhan Corporation |
2017-07-07 |
| NCT02557412 |
Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea |
https://ClinicalTrials.gov/show/NCT02557412 |
Recruiting |
Hospital Universitario La Paz |
2019-12-31 |
| NCT02541201 |
The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS) |
https://ClinicalTrials.gov/show/NCT02541201 |
Completed |
The University of Hong Kong |
2015-09-30 |
| NCT02529709 |
The Effect of Meal Composition on Blood Lipids |
https://ClinicalTrials.gov/show/NCT02529709 |
Completed |
Texas Christian University |
2016-04-30 |
| NCT02523391 |
Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 |
https://ClinicalTrials.gov/show/NCT02523391 |
Completed |
Xention Ltd |
2015-11-30 |
| NCT02484482 |
Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI) |
https://ClinicalTrials.gov/show/NCT02484482 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-08-31 |
| NCT02480816 |
Cardiometabolic Response to a Sodium-bicarbonated Mineral Water |
https://ClinicalTrials.gov/show/NCT02480816 |
Completed |
National Research Council, Spain |
2015-11-01 |
| NCT02459496 |
Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT02459496 |
Recruiting |
German Institute of Human Nutrition |
2020-12-31 |
| NCT02458287 |
Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02458287 |
Completed |
Pfizer |
2016-02-29 |
| NCT02442700 |
Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir |
https://ClinicalTrials.gov/show/NCT02442700 |
Completed |
Ramathibodi Hospital |
2015-01-31 |
| NCT02433288 |
Rosuvastatin Adherence App Study in China |
https://ClinicalTrials.gov/show/NCT02433288 |
Completed |
AstraZeneca |
2016-10-28 |
| NCT02418715 |
Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women |
https://ClinicalTrials.gov/show/NCT02418715 |
Completed |
Hospital de Clinicas de Porto Alegre |
2011-06-30 |
| NCT02407548 |
The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02407548 |
Completed |
Sun Yat-sen University |
2017-04-30 |
| NCT02380911 |
Statins at the Primary Care Level |
https://ClinicalTrials.gov/show/NCT02380911 |
Completed |
Institute for Clinical Effectiveness and Health Policy |
2017-04-30 |
| NCT02364258 |
Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients |
https://ClinicalTrials.gov/show/NCT02364258 |
Completed |
Children’s Mercy Hospital Kansas City |
2017-12-27 |
| NCT02358109 |
The Flamenco (Fitness League Against MENopause COsts) Project |
https://ClinicalTrials.gov/show/NCT02358109 |
Completed |
Universidad de Granada |
2015-11-30 |
| NCT02343497 |
Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia |
https://ClinicalTrials.gov/show/NCT02343497 |
Completed |
Ajinomoto Foods Europe SAS |
2015-09-30 |
| NCT02331043 |
Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester |
https://ClinicalTrials.gov/show/NCT02331043 |
Completed |
Raisio Group |
2013-08-31 |
| NCT02316808 |
Cholesterol-lowering Effects of Plant Stanol Ester |
https://ClinicalTrials.gov/show/NCT02316808 |
Completed |
Raisio Group |
2011-12-31 |
| NCT02312492 |
Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans |
https://ClinicalTrials.gov/show/NCT02312492 |
Completed |
Tufts University |
2016-06-30 |
| NCT02304926 |
Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02304926 |
Completed |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
2011-12-31 |
| NCT02302612 |
The CREATE Wellness Study |
https://ClinicalTrials.gov/show/NCT02302612 |
Completed |
Kaiser Permanente |
2018-09-30 |
| NCT02281253 |
Effects of a Bakery Product Enriched With Fibre and L-carnitine on Insulin Resistance in Patients With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT02281253 |
Completed |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
2012-07-31 |
| NCT02275156 |
Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab |
https://ClinicalTrials.gov/show/NCT02275156 |
Completed |
Amgen |
2014-12-19 |
| NCT02262143 |
Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02262143 |
Completed |
IlDong Pharmaceutical Co Ltd |
2016-10-31 |
| NCT02247635 |
Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women |
https://ClinicalTrials.gov/show/NCT02247635 |
Completed |
Mexican National Institute of Public Health |
2009-05-31 |
| NCT02241759 |
Study of the Electrocardiographic Effects of TA-8995 |
https://ClinicalTrials.gov/show/NCT02241759 |
Completed |
Xention Ltd |
2014-11-30 |
| NCT02236533 |
Healthy Effects of an Innovative Probiotic Pasta |
https://ClinicalTrials.gov/show/NCT02236533 |
Completed |
University of Parma |
2014-09-30 |
| NCT02230345 |
Effects of a Probiotics on the Health of Normal Young Males |
https://ClinicalTrials.gov/show/NCT02230345 |
Completed |
Centre Hospitalier Universitaire Vaudois |
2014-12-31 |
| NCT02223793 |
Vascular Lifestyle-Intervention and Screening in Pharmacy |
https://ClinicalTrials.gov/show/NCT02223793 |
Active, not recruiting |
University of Oslo |
2015-12-31 |
| NCT02221973 |
Effect of a Low Fat Milk Product on Lipids Profile in Dyslipidemia Subjects |
https://ClinicalTrials.gov/show/NCT02221973 |
Completed |
Nestlé |
2014-10-31 |
| NCT02221297 |
Lipid-lowering Effect of a Plant Stanol Ester Supplement Product |
https://ClinicalTrials.gov/show/NCT02221297 |
Completed |
Raisio Group |
2014-11-30 |
| NCT02207634 |
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects |
https://ClinicalTrials.gov/show/NCT02207634 |
Completed |
Amgen |
2016-11-11 |
| NCT02189837 |
Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody |
https://ClinicalTrials.gov/show/NCT02189837 |
Completed |
Amgen |
2015-02-13 |
| NCT02180035 |
Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS |
https://ClinicalTrials.gov/show/NCT02180035 |
Completed |
Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico |
2011-07-31 |
| NCT02166814 |
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02166814 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2015-09-30 |
| NCT02166593 |
Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin |
https://ClinicalTrials.gov/show/NCT02166593 |
Completed |
Yooyoung Pharmaceutical Co., Ltd. |
2018-01-31 |
| NCT02156544 |
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 |
https://ClinicalTrials.gov/show/NCT02156544 |
Completed |
Chong Kun Dang Pharmaceutical |
2014-10-31 |
| NCT02153879 |
Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment |
https://ClinicalTrials.gov/show/NCT02153879 |
Completed |
Institut Investigacio Sanitaria Pere Virgili |
2011-12-31 |
| NCT02145936 |
Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation |
https://ClinicalTrials.gov/show/NCT02145936 |
Completed |
Tufts University |
2017-06-30 |
| NCT02143011 |
Stress and Sugar Synergy |
https://ClinicalTrials.gov/show/NCT02143011 |
Completed |
University of California, Davis |
2016-12-31 |
| NCT02126358 |
Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) |
https://ClinicalTrials.gov/show/NCT02126358 |
Completed |
LG Life Sciences |
2016-03-31 |
| NCT02103049 |
The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients |
https://ClinicalTrials.gov/show/NCT02103049 |
Completed |
University Medical Centre Ljubljana |
2015-11-30 |
| NCT02100514 |
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events |
https://ClinicalTrials.gov/show/NCT02100514 |
Completed |
Pfizer |
2016-07-15 |
| NCT02094768 |
Soda and Milk Study |
https://ClinicalTrials.gov/show/NCT02094768 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2016-09-30 |
| NCT02073084 |
A Thorough Corrected QT Interval Trial |
https://ClinicalTrials.gov/show/NCT02073084 |
Completed |
Kowa Research Institute, Inc. |
2014-03-31 |
| NCT02066207 |
CKD-337 Drug Interaction Study |
https://ClinicalTrials.gov/show/NCT02066207 |
Completed |
Chong Kun Dang Pharmaceutical |
2014-04-07 |
| NCT01301066 |
A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects |
https://ClinicalTrials.gov/show/NCT01301066 |
Completed |
Kowa Research Institute, Inc. |
2013-03-31 |
| NCT01286311 |
Tailored Communication to Reduce Cardiovascular Risk |
https://ClinicalTrials.gov/show/NCT01286311 |
Completed |
Northwestern University |
2013-01-31 |
| NCT01285544 |
The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01285544 |
Completed |
Seoul National University Hospital |
2009-07-31 |
| NCT01282190 |
Effectiveness of Motivational Interview in Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01282190 |
Completed |
Hospital Universitario Reina Sofia de Cordoba |
2015-03-31 |
| NCT01278693 |
Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients |
https://ClinicalTrials.gov/show/NCT01278693 |
Completed |
Isfahan University of Medical Sciences |
2010-09-30 |
| NCT01271751 |
Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity |
https://ClinicalTrials.gov/show/NCT01271751 |
Completed |
Genfit |
2009-09-30 |
| NCT02057302 |
A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02057302 |
Completed |
China Academy of Chinese Medical Sciences |
2012-12-31 |
| NCT02048410 |
Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT02048410 |
Completed |
Federico II University |
2012-09-30 |
| NCT02041104 |
Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism |
https://ClinicalTrials.gov/show/NCT02041104 |
Completed |
Mlinotest Zivilska Industrija d.d. |
2018-04-30 |
| NCT02037685 |
Improving Adherence to Statins Among Minority Populations |
https://ClinicalTrials.gov/show/NCT02037685 |
Completed |
University of Miami |
2015-12-31 |
| NCT02030041 |
Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy |
https://ClinicalTrials.gov/show/NCT02030041 |
Completed |
Postgraduate Institute of Medical Education and Research |
2015-12-31 |
| NCT02029625 |
Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe |
https://ClinicalTrials.gov/show/NCT02029625 |
Completed |
Navipharm Corporation |
2014-03-31 |
| NCT02028702 |
Alternative Treatments for Menopausal Women |
https://ClinicalTrials.gov/show/NCT02028702 |
Completed |
Aarhus University Hospital |
2014-12-31 |
| NCT02013843 |
Treatment of Overweight and Obese Children -Using the “Holbaek-Method” in a Municipality Based Treatment Program. |
https://ClinicalTrials.gov/show/NCT02013843 |
Completed |
Holbaek Sygehus |
2015-03-31 |
| NCT01990391 |
Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities |
https://ClinicalTrials.gov/show/NCT01990391 |
Completed |
Universidade Federal do Rio de Janeiro |
2013-04-30 |
| NCT01975961 |
PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin |
https://ClinicalTrials.gov/show/NCT01975961 |
Completed |
Yuhan Corporation |
2013-08-31 |
| NCT03346187 |
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 |
https://ClinicalTrials.gov/show/NCT03346187 |
Completed |
Chong Kun Dang Pharmaceutical |
2017-05-31 |
| NCT01972113 |
Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K ‘n’ Kids Study) |
https://ClinicalTrials.gov/show/NCT01972113 |
Recruiting |
Augusta University |
2020-08-30 |
| NCT01970215 |
TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) |
https://ClinicalTrials.gov/show/NCT01970215 |
Completed |
Xention Ltd |
2014-07-31 |
| NCT01968967 |
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events |
https://ClinicalTrials.gov/show/NCT01968967 |
Completed |
Pfizer |
2016-07-05 |
| NCT01968954 |
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events |
https://ClinicalTrials.gov/show/NCT01968954 |
Completed |
Pfizer |
2016-04-30 |
| NCT01968720 |
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia |
https://ClinicalTrials.gov/show/NCT01968720 |
Completed |
Catabasis Pharmaceuticals |
2014-04-30 |
| NCT01967355 |
Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis |
https://ClinicalTrials.gov/show/NCT01967355 |
Completed |
University Hospital Freiburg |
2014-05-08 |
| NCT01958775 |
Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2 |
https://ClinicalTrials.gov/show/NCT01958775 |
Completed |
University Health Network, Toronto |
2014-06-30 |
| NCT01953328 |
Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk |
https://ClinicalTrials.gov/show/NCT01953328 |
Completed |
Amgen |
2014-06-30 |
| NCT01912560 |
Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01912560 |
Completed |
Catabasis Pharmaceuticals |
2013-12-31 |
| NCT01893515 |
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects |
https://ClinicalTrials.gov/show/NCT01893515 |
Completed |
Pronova BioPharma |
2014-07-31 |
| NCT01884714 |
Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study |
https://ClinicalTrials.gov/show/NCT01884714 |
Completed |
University of Guelph |
2013-12-31 |
| NCT01883401 |
Chronic Effects of Freeze-Dried Strawberry Beverage on Cardiovascular Risk Factors |
https://ClinicalTrials.gov/show/NCT01883401 |
Completed |
Oklahoma State University |
2013-03-31 |
| NCT01882517 |
Lipid-lowering Effect of Plant Stanol Yogurt |
https://ClinicalTrials.gov/show/NCT01882517 |
Completed |
Raisio Group |
2012-01-31 |
| NCT01879319 |
Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen |
https://ClinicalTrials.gov/show/NCT01879319 |
Completed |
Amgen |
2013-12-31 |
| NCT01879020 |
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01879020 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2010-06-30 |
| NCT01878474 |
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01878474 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2009-06-30 |
| NCT01854918 |
Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01854918 |
Completed |
Amgen |
2018-05-31 |
| NCT01849497 |
Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen |
https://ClinicalTrials.gov/show/NCT01849497 |
Completed |
Amgen |
2013-09-02 |
| NCT01806506 |
Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity |
https://ClinicalTrials.gov/show/NCT01806506 |
Completed |
Medical University of Warsaw |
2012-03-31 |
| NCT01806142 |
Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT01806142 |
Completed |
Laval University |
2012-04-30 |
| NCT01803594 |
Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism |
https://ClinicalTrials.gov/show/NCT01803594 |
Active, not recruiting |
University of California, Davis |
2027-03-13 |
| NCT01792648 |
Effects of Almond Intake on Atherogenic Lipoprotein Particles |
https://ClinicalTrials.gov/show/NCT01792648 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2016-02-29 |
| NCT01778244 |
Metformin for Treatment of Antipsychotic-induced Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01778244 |
Completed |
Central South University |
2011-12-31 |
| NCT01768481 |
Intima Media Thickness Regression in Dyslipidemic Teenagers |
https://ClinicalTrials.gov/show/NCT01768481 |
Completed |
Université de Montréal |
2009-12-31 |
| NCT01764633 |
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk |
https://ClinicalTrials.gov/show/NCT01764633 |
Completed |
Amgen |
2016-11-11 |
| NCT01764295 |
Clinical Study for Patients With Hypertension Associated With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01764295 |
Completed |
Daewoong Pharmaceutical Co. LTD. |
2013-05-31 |
| NCT01760460 |
A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) |
https://ClinicalTrials.gov/show/NCT01760460 |
Completed |
Merck Sharp & Dohme Corp. |
2015-03-04 |
| NCT01729156 |
Effects of Metformin on Hepatic FFA Metabolism |
https://ClinicalTrials.gov/show/NCT01729156 |
Completed |
University of Aarhus |
2017-05-05 |
| NCT01725594 |
A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 |
https://ClinicalTrials.gov/show/NCT01725594 |
Completed |
Catabasis Pharmaceuticals |
2013-05-31 |
| NCT01696097 |
The Effects of Pork vs. Chicken/Fish in a DASH Diet on Blood Pressure Regulation in Middle Aged and Older Adults |
https://ClinicalTrials.gov/show/NCT01696097 |
Completed |
Purdue University |
2014-02-28 |
| NCT01695837 |
Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01695837 |
Completed |
University of Nevada, Las Vegas |
2012-05-31 |
| NCT01674712 |
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT01674712 |
Completed |
Abbott |
2013-10-31 |
| NCT01651065 |
Micro-Clinic Obesity and Metabolic Risk Prevention Program |
https://ClinicalTrials.gov/show/NCT01651065 |
Completed |
Microclinic International |
2014-12-31 |
| NCT01632358 |
Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients |
https://ClinicalTrials.gov/show/NCT01632358 |
Completed |
Novartis |
2012-12-31 |
| NCT01610661 |
Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators |
https://ClinicalTrials.gov/show/NCT01610661 |
Completed |
Tufts University |
2015-04-30 |
| NCT01603758 |
Physiological Study of Human Cholesterol Metabolism and Excretion |
https://ClinicalTrials.gov/show/NCT01603758 |
Completed |
Washington University School of Medicine |
2015-06-30 |
| NCT01600690 |
Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients |
https://ClinicalTrials.gov/show/NCT01600690 |
Completed |
University of Padova |
2013-08-31 |
| NCT01581372 |
A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets |
https://ClinicalTrials.gov/show/NCT01581372 |
Completed |
University of Alberta |
2013-01-31 |
| NCT01562782 |
Change of Fructose to Fat in South Asians |
https://ClinicalTrials.gov/show/NCT01562782 |
Completed |
The Rogosin Institute |
2013-10-10 |
| NCT01559441 |
Beetroot Juice and Postprandial Vascular Activity |
https://ClinicalTrials.gov/show/NCT01559441 |
Completed |
Maastricht University Medical Center |
2012-08-31 |
| NCT01551173 |
Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01551173 |
Completed |
Novartis |
2013-05-31 |
| NCT01539616 |
A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01539616 |
Completed |
Cadila Healthcare Limited |
2012-06-30 |
| NCT01531062 |
Effect of Nigella Sativa on Lipid Profiles in Elderly |
https://ClinicalTrials.gov/show/NCT01531062 |
Completed |
Indonesia University |
2011-12-31 |
| NCT01516541 |
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT01516541 |
Completed |
Hoffmann-La Roche |
2012-07-31 |
| NCT01502904 |
Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents |
https://ClinicalTrials.gov/show/NCT01502904 |
Completed |
Yonsei University |
2015-05-31 |
| NCT01497912 |
Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT01497912 |
Completed |
Karolinska Institutet |
2009-01-31 |
| NCT01487460 |
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients |
https://ClinicalTrials.gov/show/NCT01487460 |
Completed |
Novartis |
2012-06-30 |
| NCT01483235 |
Reduced Cardiac Rehabilitation Program |
https://ClinicalTrials.gov/show/NCT01483235 |
Completed |
Simon Fraser University |
2011-09-30 |
| NCT01474161 |
Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 |
https://ClinicalTrials.gov/show/NCT01474161 |
Completed |
Genfit |
2012-11-30 |
| NCT01462877 |
A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic |
https://ClinicalTrials.gov/show/NCT01462877 |
Completed |
Abbott |
2014-02-28 |
| NCT01458977 |
Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors |
https://ClinicalTrials.gov/show/NCT01458977 |
Completed |
Fundacio Lluita Contra la SIDA |
2014-02-28 |
| NCT01451918 |
Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol |
https://ClinicalTrials.gov/show/NCT01451918 |
Completed |
University Health Network, Toronto |
2013-09-30 |
| NCT01435382 |
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01435382 |
Completed |
Pfizer |
2012-02-29 |
| NCT01427855 |
Dietary Protein Sources and Atherogenic Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01427855 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2016-11-30 |
| NCT01423188 |
The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation |
https://ClinicalTrials.gov/show/NCT01423188 |
Completed |
Resverlogix Corp |
2012-06-30 |
| NCT01422421 |
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease |
https://ClinicalTrials.gov/show/NCT01422421 |
Recruiting |
Kyoto University, Graduate School of Medicine |
2022-03-31 |
| NCT01420549 |
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01420549 |
Completed |
Ache Laboratorios Farmaceuticos S.A. |
2014-11-30 |
| NCT01418716 |
TRANSforming InTerprofessional Cardiovascular Prevention in Primary Care |
https://ClinicalTrials.gov/show/NCT01418716 |
Completed |
Fonds de la Recherche en Santé du Québec |
2013-10-31 |
| NCT01414647 |
The Health Effect of Diet Rich in Nordic Berries |
https://ClinicalTrials.gov/show/NCT01414647 |
Completed |
University of Eastern Finland |
2006-12-31 |
| NCT01404897 |
Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals |
https://ClinicalTrials.gov/show/NCT01404897 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2013-12-31 |
| NCT01402843 |
Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01402843 |
Completed |
JW Pharmaceutical |
2012-06-30 |
| NCT01394380 |
Reduction of Sweetened Beverages and Intrahepatic Fat |
https://ClinicalTrials.gov/show/NCT01394380 |
Completed |
University of Lausanne |
2014-04-30 |
| NCT01375075 |
A Study of LY2484595 in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT01375075 |
Completed |
Eli Lilly and Company |
2012-03-31 |
| NCT01364961 |
Resveratrol and Serum Apo A-I |
https://ClinicalTrials.gov/show/NCT01364961 |
Completed |
Maastricht University Medical Center |
2012-12-31 |
| NCT01350843 |
The Effects of Orange Juice on Plasma Lipids |
https://ClinicalTrials.gov/show/NCT01350843 |
Completed |
University of Nottingham |
2012-12-31 |
| NCT01350141 |
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins |
https://ClinicalTrials.gov/show/NCT01350141 |
Completed |
Pfizer |
2012-04-30 |
| NCT01342211 |
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins |
https://ClinicalTrials.gov/show/NCT01342211 |
Completed |
Pfizer |
2012-02-29 |
| NCT01333436 |
A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1) |
https://ClinicalTrials.gov/show/NCT01333436 |
Completed |
Merck Sharp & Dohme Corp. |
2012-05-12 |
| NCT04447820 |
Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR |
https://ClinicalTrials.gov/show/NCT04447820 |
Recruiting |
Kowa Research Institute, Inc. |
2020-12-29 |
| NCT04439474 |
Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT04439474 |
Completed |
Baqiyatallah Medical Sciences University |
2019-11-10 |
| NCT04437459 |
The Reproducibility and Clinical Utility of an Abbreviated Fat Tolerance Test |
https://ClinicalTrials.gov/show/NCT04437459 |
Completed |
Oklahoma State University |
2019-07-31 |
| NCT03583905 |
Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet |
https://ClinicalTrials.gov/show/NCT03583905 |
Completed |
Chong Kun Dang Pharmaceutical |
2019-07-17 |
| NCT04388215 |
Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet |
https://ClinicalTrials.gov/show/NCT04388215 |
Recruiting |
Chong Kun Dang Pharmaceutical |
2021-04-30 |
| NCT04348019 |
Effects of a Daily Time-Restricted Feeding Protocol on Diet Quality |
https://ClinicalTrials.gov/show/NCT04348019 |
Active, not recruiting |
Arizona State University |
2020-04-30 |
| NCT04319029 |
Assessment of Dyslipidemic Patients’ Knowledge, Quality of Life, and Adherence |
https://ClinicalTrials.gov/show/NCT04319029 |
Completed |
Al-Rasheed University College |
2019-07-01 |
| NCT04258865 |
A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 |
https://ClinicalTrials.gov/show/NCT04258865 |
Completed |
Chong Kun Dang Pharmaceutical |
2020-04-26 |
| NCT04233528 |
Evaluation of Systemic Microvascular Endothelial Function in Metabolically Healthy Obesity |
https://ClinicalTrials.gov/show/NCT04233528 |
Recruiting |
National Institute of Cardiology, Laranjeiras, Brazil |
2022-06-30 |
| NCT04186780 |
Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study |
https://ClinicalTrials.gov/show/NCT04186780 |
Completed |
University of Sorocaba |
2018-12-01 |
| NCT04161001 |
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 |
https://ClinicalTrials.gov/show/NCT04161001 |
Recruiting |
Daewoong Pharmaceutical Co. LTD. |
2021-11-20 |
| NCT04155645 |
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT04155645 |
Recruiting |
AstraZeneca |
2021-04-30 |
| NCT04153617 |
Enriched Honey With Soluble Fiber and Polyphenols on Satiety and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT04153617 |
Completed |
Instituto de Investigación Hospital Universitario La Paz |
2019-04-19 |
| NCT04148976 |
Effect of Dietary Intervention on LDL-C and Lipoprotein Subclasses Distribution in Patients With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT04148976 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2018-12-18 |
| NCT04128969 |
Causal Mechanisms in Adolescent Arterial Stiffness |
https://ClinicalTrials.gov/show/NCT04128969 |
Recruiting |
Baylor College of Medicine |
2024-05-30 |
| NCT04120753 |
Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT04120753 |
Recruiting |
Daewoong Pharmaceutical Co. LTD. |
2020-02-29 |
| NCT04114513 |
Dietary Fibers Effect on the Gut Microbiota Composition |
https://ClinicalTrials.gov/show/NCT04114513 |
Recruiting |
Atlas Biomed |
2021-06-01 |
| NCT04079530 |
A Clinical Pharmacology Study of K-877 Controlled Release Tablet |
https://ClinicalTrials.gov/show/NCT04079530 |
Active, not recruiting |
Kowa Company, Ltd. |
2020-03-31 |
| NCT04074551 |
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT04074551 |
Recruiting |
Hanmi Pharmaceutical Company Limited |
2020-03-31 |
| NCT04061824 |
Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT04061824 |
Completed |
Yonsei University |
2018-12-20 |
| NCT04055168 |
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04055168 |
Recruiting |
AstraZeneca |
2021-08-06 |
| NCT04037943 |
NUTS for the Prevention of Cardiovascular Disease in Chinese Adults |
https://ClinicalTrials.gov/show/NCT04037943 |
Active, not recruiting |
The George Institute for Global Health, China |
2020-06-30 |
| NCT04019743 |
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04019743 |
Completed |
Chong Kun Dang Pharmaceutical |
2019-08-30 |
| NCT04014686 |
12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT04014686 |
Completed |
University of Nebraska, Omaha |
2018-08-01 |
| NCT04008693 |
Aging, Aged Garlic, Vascular Function and Muscle Oxygenation |
https://ClinicalTrials.gov/show/NCT04008693 |
Completed |
Universidade Federal do Rio de Janeiro |
2020-01-30 |
| NCT04003259 |
Get-a-Grip Lifestyle Management Programme |
https://ClinicalTrials.gov/show/NCT04003259 |
Completed |
Tampere University |
2013-12-31 |
| NCT03988101 |
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event |
https://ClinicalTrials.gov/show/NCT03988101 |
Recruiting |
Yonsei University |
2021-02-28 |
| NCT03975556 |
Culturally-Adapted Diet for Puerto Rican Adults |
https://ClinicalTrials.gov/show/NCT03975556 |
Recruiting |
Harvard School of Public Health |
2020-07-31 |
| NCT03961763 |
Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins |
https://ClinicalTrials.gov/show/NCT03961763 |
Completed |
University of Chester |
2017-11-01 |
| NCT03960541 |
CD24Fc Administration to Decrease LDL and Inflammation in HIV Patients (CALIBER) |
https://ClinicalTrials.gov/show/NCT03960541 |
Recruiting |
OncoImmune, Inc. |
2021-10-31 |
| NCT03951207 |
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03951207 |
Recruiting |
Yuhan Corporation |
2020-08-30 |
| NCT03949374 |
Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients |
https://ClinicalTrials.gov/show/NCT03949374 |
Completed |
Yonsei University |
2018-04-16 |
| NCT03937960 |
Effect of Low Carbohydrate Versus Low Fat Diet in the Treatment of Dyslipidemia in Obese Children With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT03937960 |
Recruiting |
University of Alabama at Birmingham |
2020-06-30 |
| NCT03932721 |
EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial |
https://ClinicalTrials.gov/show/NCT03932721 |
Recruiting |
University of Campinas, Brazil |
2020-06-30 |
| NCT03920579 |
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT03920579 |
Recruiting |
Chong Kun Dang Pharmaceutical |
2019-05-31 |
| NCT03906539 |
Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03906539 |
Recruiting |
All India Institute of Medical Sciences, Bhubaneswar |
2021-01-31 |
| NCT03885661 |
Vascepa to Accelerate Lipoprotein Uptake and Elimination |
https://ClinicalTrials.gov/show/NCT03885661 |
Active, not recruiting |
University of Pennsylvania |
2019-12-31 |
| NCT03874260 |
Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy |
https://ClinicalTrials.gov/show/NCT03874260 |
Recruiting |
Daewon Pharmaceutical Co., Ltd. |
2020-01-31 |
| NCT03805776 |
Intermittent Fasting in Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03805776 |
Recruiting |
Aga Khan University |
2019-06-01 |
| NCT03795038 |
Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI |
https://ClinicalTrials.gov/show/NCT03795038 |
Recruiting |
Fresenius Medical Care Deutschland GmbH |
2019-12-31 |
| NCT03773315 |
Ulmus Macrocarpa Hance Extract and Lipid Profile |
https://ClinicalTrials.gov/show/NCT03773315 |
Completed |
Pusan National University Yangsan Hospital |
2020-02-14 |
| NCT03747224 |
Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients |
https://ClinicalTrials.gov/show/NCT03747224 |
Recruiting |
Arrowhead Pharmaceuticals |
2020-05-30 |
| NCT03742219 |
Peru Longitudinal Study |
https://ClinicalTrials.gov/show/NCT03742219 |
Recruiting |
Ohio University |
2026-07-01 |
| NCT03740074 |
Personal Activity Intelligence (PAI) Pilot |
https://ClinicalTrials.gov/show/NCT03740074 |
Recruiting |
Ohio University |
2019-06-30 |
| NCT03739034 |
Evaluation of a Lifestyle Medicine Practice |
https://ClinicalTrials.gov/show/NCT03739034 |
Recruiting |
Ohio University |
2027-06-30 |
| NCT03728621 |
Lifestyle Interventions and Metabolic Profile in Obese Children |
https://ClinicalTrials.gov/show/NCT03728621 |
Completed |
University of Milan |
2017-06-30 |
| NCT03726866 |
A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT03726866 |
Recruiting |
Chong Kun Dang Pharmaceutical |
2019-01-15 |
| NCT03718286 |
Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI |
https://ClinicalTrials.gov/show/NCT03718286 |
Recruiting |
Population Health Research Institute |
2020-07-31 |
| NCT03707899 |
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers |
https://ClinicalTrials.gov/show/NCT03707899 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2019-02-18 |
| NCT03676309 |
Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia. |
https://ClinicalTrials.gov/show/NCT03676309 |
Completed |
Villa dei Gerani |
2018-03-26 |
| NCT03659149 |
Pharmacokinetics and Safety Profile of CKD-333 |
https://ClinicalTrials.gov/show/NCT03659149 |
Completed |
Chong Kun Dang Pharmaceutical |
2018-10-05 |
| NCT03619421 |
Zinc Supplement Before or With Food in Generally Healthy Men |
https://ClinicalTrials.gov/show/NCT03619421 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2019-04-15 |
| NCT03618797 |
A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia |
https://ClinicalTrials.gov/show/NCT03618797 |
Completed |
Hanlim Pharm. Co., Ltd. |
2018-01-31 |
| NCT03615534 |
Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females |
https://ClinicalTrials.gov/show/NCT03615534 |
Completed |
Al-Kindy College of Medicine |
2015-06-30 |
| NCT03611010 |
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients |
https://ClinicalTrials.gov/show/NCT03611010 |
Completed |
Cumberland Pharmaceuticals |
2020-02-17 |
| NCT03609606 |
A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT03609606 |
Completed |
Chong Kun Dang Pharmaceutical |
2018-09-14 |
| NCT03607383 |
Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study |
https://ClinicalTrials.gov/show/NCT03607383 |
Recruiting |
Saint-Joseph University |
2020-04-30 |
| NCT03606824 |
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study) |
https://ClinicalTrials.gov/show/NCT03606824 |
Recruiting |
China National Center for Cardiovascular Diseases |
2020-02-28 |
| NCT03577275 |
A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval |
https://ClinicalTrials.gov/show/NCT03577275 |
Completed |
NorthSea Therapeutics B.V. |
2018-09-15 |
| NCT03557476 |
Effects of Octacosanol During Taekwondo Training |
https://ClinicalTrials.gov/show/NCT03557476 |
Completed |
University of Nebraska, Omaha |
2018-03-01 |
| NCT03532620 |
China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension |
https://ClinicalTrials.gov/show/NCT03532620 |
Recruiting |
First Affiliated Hospital, Sun Yat-Sen University |
2019-09-30 |
| NCT03527290 |
Dietary Approaches for Cardiometabolic Health |
https://ClinicalTrials.gov/show/NCT03527290 |
Completed |
University of California, Irvine |
2018-07-31 |
| NCT03502109 |
Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients. |
https://ClinicalTrials.gov/show/NCT03502109 |
Completed |
Pontificia Universidad Catolica de Chile |
2019-06-30 |
| NCT02125682 |
The HDL Particle Protection Study |
https://ClinicalTrials.gov/show/NCT02125682 |
Completed |
Hotel Dieu de France Hospital |
2017-05-14 |
| NCT03482180 |
Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled |
https://ClinicalTrials.gov/show/NCT03482180 |
Completed |
Kuhnil Pharmaceutical Co., Ltd. |
2017-05-16 |
| NCT04456192 |
Effects of an Indoor Cycling Program on Cardio-Metabolic Factors in Women With Obesity and Normal Body Weight |
https://ClinicalTrials.gov/show/NCT04456192 |
Completed |
Poznan University of Physical Education |
2016-06-15 |
| NCT03451214 |
Evaluation of Zinc Intake on Essential Fatty Acid Metabolism |
https://ClinicalTrials.gov/show/NCT03451214 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2018-06-30 |
| NCT03434613 |
A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03434613 |
Completed |
Yonsei University |
2019-09-11 |
| NCT03433755 |
Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Subjects With Primary Hypercholesterolemia and Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03433755 |
Active, not recruiting |
Amgen |
2021-08-23 |
| NCT03415503 |
Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner |
https://ClinicalTrials.gov/show/NCT03415503 |
Completed |
Sun Yat-sen University |
2019-10-01 |
| NCT01262638 |
A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides |
https://ClinicalTrials.gov/show/NCT01262638 |
Completed |
Esperion Therapeutics |
2011-10-31 |
| NCT01256476 |
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01256476 |
Completed |
Kowa Research Institute, Inc. |
2011-06-30 |
| NCT01250990 |
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis |
https://ClinicalTrials.gov/show/NCT01250990 |
Completed |
University of Pennsylvania |
2011-05-31 |
| NCT01243151 |
Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01243151 |
Completed |
Pfizer |
2011-10-31 |
| NCT01239004 |
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy |
https://ClinicalTrials.gov/show/NCT01239004 |
Completed |
Radiant Research |
2011-08-31 |
| NCT01218204 |
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin |
https://ClinicalTrials.gov/show/NCT01218204 |
Completed |
GlaxoSmithKline |
2011-06-29 |
| NCT01217112 |
GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes |
https://ClinicalTrials.gov/show/NCT01217112 |
Completed |
GW Research Ltd |
2012-05-31 |
| NCT01216956 |
Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01216956 |
Completed |
Centre de Recherche en Nutrition Humaine Rhone-Alpe |
2009-06-30 |
| NCT01211847 |
Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia |
https://ClinicalTrials.gov/show/NCT01211847 |
Completed |
Essentialis, Inc. |
2011-09-30 |
| NCT01205750 |
Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics |
https://ClinicalTrials.gov/show/NCT01205750 |
Completed |
University of Aarhus |
2010-09-30 |
| NCT01165853 |
Effects of Consuming Sugar-Sweetened Beverages With Meals for 10 Weeks |
https://ClinicalTrials.gov/show/NCT01165853 |
Completed |
University of California, Davis |
2007-11-30 |
| NCT01163851 |
Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin |
https://ClinicalTrials.gov/show/NCT01163851 |
Completed |
Pfizer |
2011-02-28 |
| NCT01122667 |
Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038) |
https://ClinicalTrials.gov/show/NCT01122667 |
Completed |
Merck Sharp & Dohme Corp. |
2011-06-30 |
| NCT01114490 |
Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) |
https://ClinicalTrials.gov/show/NCT01114490 |
Completed |
Merck Sharp & Dohme Corp. |
2010-07-31 |
| NCT01113099 |
Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients |
https://ClinicalTrials.gov/show/NCT01113099 |
Completed |
Washington University School of Medicine |
2007-06-30 |
| NCT01112423 |
Safety Study of BMS-823778 in Subjects With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01112423 |
Completed |
Bristol-Myers Squibb |
2010-12-31 |
| NCT01105975 |
A Study of LY2484595 in Patients With High LDL-C or Low HDL-C |
https://ClinicalTrials.gov/show/NCT01105975 |
Completed |
Eli Lilly and Company |
2011-06-30 |
| NCT01105598 |
A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01105598 |
Completed |
Esperion Therapeutics |
2010-10-02 |
| NCT01104519 |
A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093) |
https://ClinicalTrials.gov/show/NCT01104519 |
Completed |
Merck Sharp & Dohme Corp. |
2008-07-31 |
| NCT01103921 |
The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks |
https://ClinicalTrials.gov/show/NCT01103921 |
Completed |
University of California, Davis |
2014-01-31 |
| NCT01071291 |
Effects of Niaspanâ„¢ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) |
https://ClinicalTrials.gov/show/NCT01071291 |
Completed |
Merck Sharp & Dohme Corp. |
2010-08-31 |
| NCT01069783 |
Study of A3309 in Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01069783 |
Completed |
Albireo |
2010-09-30 |
| NCT01058083 |
Safety Study of BMS-770767 in Subjects With Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT01058083 |
Completed |
Bristol-Myers Squibb |
2011-03-31 |
| NCT01029522 |
Dyslipidemia in Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT01029522 |
Completed |
Chong Kun Dang Pharmaceutical |
2008-10-31 |
| NCT01027325 |
Resistant Starch Insulin Sensitivity Trial |
https://ClinicalTrials.gov/show/NCT01027325 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2011-08-31 |
| NCT00990808 |
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) |
https://ClinicalTrials.gov/show/NCT00990808 |
Completed |
Merck Sharp & Dohme Corp. |
2011-06-30 |
| NCT00986986 |
Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels |
https://ClinicalTrials.gov/show/NCT00986986 |
Completed |
University of Hawaii |
2010-04-30 |
| NCT00979368 |
Safety Study of BMS-816336 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT00979368 |
Completed |
Bristol-Myers Squibb |
2010-02-28 |
| NCT00977288 |
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029) |
https://ClinicalTrials.gov/show/NCT00977288 |
Completed |
Merck Sharp & Dohme Corp. |
2010-03-31 |
| NCT00961636 |
A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102) |
https://ClinicalTrials.gov/show/NCT00961636 |
Completed |
Merck Sharp & Dohme Corp. |
2011-01-31 |
| NCT00944645 |
MK0524A Bioequivalence Study (0524A-059) |
https://ClinicalTrials.gov/show/NCT00944645 |
Completed |
Merck Sharp & Dohme Corp. |
2007-01-31 |
| NCT00943124 |
MK0524B Bioequivalence Study (0524B-070) |
https://ClinicalTrials.gov/show/NCT00943124 |
Completed |
Merck Sharp & Dohme Corp. |
2007-08-31 |
| NCT00935259 |
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00935259 |
Completed |
Merck Sharp & Dohme Corp. |
2009-10-31 |
| NCT00928694 |
Fenofibrate Bioequivalence Study (0767-031) |
https://ClinicalTrials.gov/show/NCT00928694 |
Completed |
Merck Sharp & Dohme Corp. |
2003-04-30 |
| NCT00903617 |
Study to Test GSK256073 in Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00903617 |
Completed |
GlaxoSmithKline |
2010-02-16 |
| NCT00895141 |
Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL) |
https://ClinicalTrials.gov/show/NCT00895141 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2010-09-30 |
| NCT00858637 |
Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis |
https://ClinicalTrials.gov/show/NCT00858637 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2010-03-31 |
| NCT00854503 |
Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients |
https://ClinicalTrials.gov/show/NCT00854503 |
Completed |
University of Rome Tor Vergata |
2010-03-31 |
| NCT00852267 |
Lipoprotein Effects of Substituting Beef Protein for Carbohydrate |
https://ClinicalTrials.gov/show/NCT00852267 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2009-08-31 |
| NCT00847197 |
A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004) |
https://ClinicalTrials.gov/show/NCT00847197 |
Completed |
Merck Sharp & Dohme Corp. |
2009-09-30 |
| NCT00845637 |
Effect of Eggplant Extract on Lipid Profile During Fasting and Postprandial Period |
https://ClinicalTrials.gov/show/NCT00845637 |
Completed |
Hospital de Clinicas de Porto Alegre |
2007-03-31 |
| NCT04312698 |
Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 |
https://ClinicalTrials.gov/show/NCT04312698 |
Recruiting |
Chong Kun Dang Pharmaceutical |
2020-09-29 |
| NCT04085874 |
Effectiveness of Food-Based Recommendations for Minangkabau Women of Reproductive Age With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT04085874 |
Completed |
Politeknik Kesehatan Kemenkes Padang |
2019-05-05 |
| NCT03878290 |
RiSE to Prevent Cardiovascular Disease in African Americans |
https://ClinicalTrials.gov/show/NCT03878290 |
Completed |
Loyola University |
2019-07-01 |
| NCT03805139 |
Role of Ajwa Derived Polyphenols in Dyslipidaemias |
https://ClinicalTrials.gov/show/NCT03805139 |
Recruiting |
Aga Khan University |
2019-11-07 |
| NCT02833844 |
Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02833844 |
Completed |
Amgen |
2019-07-09 |
| NCT00829348 |
Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins |
https://ClinicalTrials.gov/show/NCT00829348 |
Completed |
Hillel Yaffe Medical Center |
2009-07-31 |
| NCT00861861 |
Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD) |
https://ClinicalTrials.gov/show/NCT00861861 |
Completed |
Kumamoto University |
2013-10-31 |
| NCT03156842 |
Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT03156842 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2018-12-07 |
| NCT00812955 |
Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol (“Bad Cholesterol”) and Triglycerides |
https://ClinicalTrials.gov/show/NCT00812955 |
Completed |
AstraZeneca |
2009-06-30 |
| NCT00808093 |
Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT00808093 |
Completed |
GlaxoSmithKline |
2008-08-27 |
| NCT02767440 |
Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity |
https://ClinicalTrials.gov/show/NCT02767440 |
Completed |
Duke University |
2017-06-30 |
| NCT02623868 |
Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. |
https://ClinicalTrials.gov/show/NCT02623868 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-12-31 |
| NCT02408055 |
ADME Study in Healthy Male Subjects With TA-8995 |
https://ClinicalTrials.gov/show/NCT02408055 |
Completed |
Xention Ltd |
2015-08-31 |
| NCT02181244 |
Egg Effects on Atherogenic Dyslipidemias, Glucose Metabolism and Inflammation in Diabetic Subjects |
https://ClinicalTrials.gov/show/NCT02181244 |
Completed |
University of Connecticut |
2014-01-31 |
| NCT02168803 |
A Study of Evacetrapib in Participants With Abnormal Cholesterol |
https://ClinicalTrials.gov/show/NCT02168803 |
Completed |
Eli Lilly and Company |
2015-12-31 |
| NCT01984073 |
Effects of Niacin On Fatty Acid Trapping |
https://ClinicalTrials.gov/show/NCT01984073 |
Active, not recruiting |
University of Pennsylvania |
2019-12-31 |
| NCT01686451 |
The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin |
https://ClinicalTrials.gov/show/NCT01686451 |
Completed |
Wenzhou Medical University |
2013-09-30 |
| NCT04270084 |
Metabolic Optimization Through Diet/Lifestyle Improvements For Youth |
https://ClinicalTrials.gov/show/NCT04270084 |
Recruiting |
Children’s National Research Institute |
2020-06-30 |
| NCT04110392 |
Effect of Consumption of Chaya on Lipid Concentration and Antioxidant Status of Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT04110392 |
Recruiting |
Hospital Regional de Alta Especialidad de la PenÃnsula de Yucatán |
2019-09-23 |
| NCT04067297 |
Using Big Data to Conduct Innovative Cardiovascular Clinical Trials |
https://ClinicalTrials.gov/show/NCT04067297 |
Recruiting |
Institute for Clinical Evaluative Sciences |
2021-03-31 |
| NCT03696940 |
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population |
https://ClinicalTrials.gov/show/NCT03696940 |
Active, not recruiting |
Laboratorios Grossman, S.A. |
2019-03-01 |
| NCT02455336 |
Fenofibrate Treatment in SCI |
https://ClinicalTrials.gov/show/NCT02455336 |
Completed |
VA Office of Research and Development |
2018-08-01 |
| NCT00783549 |
A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs. |
https://ClinicalTrials.gov/show/NCT00783549 |
Completed |
GlaxoSmithKline |
2009-03-31 |
| NCT00770653 |
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. |
https://ClinicalTrials.gov/show/NCT00770653 |
Completed |
Takeda |
2009-05-31 |
| NCT00768274 |
Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol |
https://ClinicalTrials.gov/show/NCT00768274 |
Completed |
Resverlogix Corp |
2009-08-31 |
| NCT00749788 |
Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels |
https://ClinicalTrials.gov/show/NCT00749788 |
Completed |
Akros Pharma Inc. |
2008-02-29 |
| NCT00748852 |
Safety Study of JTT-302 in Subjects With Low HDL-C Levels |
https://ClinicalTrials.gov/show/NCT00748852 |
Completed |
Akros Pharma Inc. |
2008-03-31 |
| NCT00746460 |
The Healthy Options Feasibility Study |
https://ClinicalTrials.gov/show/NCT00746460 |
Completed |
McGill University |
2009-04-30 |
| NCT00708370 |
A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. |
https://ClinicalTrials.gov/show/NCT00708370 |
Completed |
Pfizer |
2010-05-31 |
| NCT00707746 |
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects |
https://ClinicalTrials.gov/show/NCT00707746 |
Completed |
Kastle Therapeutics, LLC |
2010-08-31 |
| NCT00700037 |
Change in Plaque Characteristics With Atorvastatin |
https://ClinicalTrials.gov/show/NCT00700037 |
Completed |
Wakayama Medical University |
2012-02-29 |
| NCT00697203 |
A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C) |
https://ClinicalTrials.gov/show/NCT00697203 |
Completed |
Hoffmann-La Roche |
2006-05-31 |
| NCT00694239 |
Risk Assessment and Treat Compliance in Hypertension Education Trial |
https://ClinicalTrials.gov/show/NCT00694239 |
Completed |
Lawson Health Research Institute |
2011-03-31 |
| NCT00694109 |
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00694109 |
Completed |
Kastle Therapeutics, LLC |
2014-09-30 |
| NCT00689442 |
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels |
https://ClinicalTrials.gov/show/NCT00689442 |
Completed |
Akros Pharma Inc. |
2004-11-30 |
| NCT00688558 |
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels |
https://ClinicalTrials.gov/show/NCT00688558 |
Completed |
Akros Pharma Inc. |
2004-12-31 |
| NCT00680017 |
30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT00680017 |
Completed |
AstraZeneca |
2011-04-30 |
| NCT00673881 |
ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study |
https://ClinicalTrials.gov/show/NCT00673881 |
Completed |
Radiant Research |
2009-05-31 |
| NCT00666250 |
Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors |
https://ClinicalTrials.gov/show/NCT00666250 |
Completed |
University of Utah |
2008-04-30 |
| NCT00665834 |
Comparison of Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome |
https://ClinicalTrials.gov/show/NCT00665834 |
Completed |
Queen’s University |
2007-09-30 |
| NCT00664859 |
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00664859 |
Completed |
Veloxis Pharmaceuticals |
2009-02-28 |
| NCT00659321 |
Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00659321 |
Completed |
GWT-TUD GmbH |
2008-09-30 |
| NCT00654628 |
Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00654628 |
Completed |
Merck Sharp & Dohme Corp. |
2009-07-01 |
| NCT00654602 |
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety |
https://ClinicalTrials.gov/show/NCT00654602 |
Completed |
AstraZeneca |
NA |
| NCT00654446 |
IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin |
https://ClinicalTrials.gov/show/NCT00654446 |
Completed |
AstraZeneca |
NA |
| NCT00654225 |
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) |
https://ClinicalTrials.gov/show/NCT00654225 |
Completed |
AstraZeneca |
NA |
| NCT00653744 |
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) |
https://ClinicalTrials.gov/show/NCT00653744 |
Completed |
AstraZeneca |
NA |
| NCT00651963 |
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00651963 |
Completed |
Merck Sharp & Dohme Corp. |
2005-03-31 |
| NCT00647543 |
Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand |
https://ClinicalTrials.gov/show/NCT00647543 |
Completed |
Pfizer |
NA |
| NCT00645775 |
Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00645775 |
Completed |
Gateway Health Alliance |
2007-03-31 |
| NCT00645151 |
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol |
https://ClinicalTrials.gov/show/NCT00645151 |
Completed |
Pfizer |
NA |
| NCT00644709 |
A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) |
https://ClinicalTrials.gov/show/NCT00644709 |
Completed |
Pfizer |
NA |
| NCT00644670 |
A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol |
https://ClinicalTrials.gov/show/NCT00644670 |
Completed |
Pfizer |
NA |
| NCT00639158 |
Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood |
https://ClinicalTrials.gov/show/NCT00639158 |
Completed |
Abbott |
2008-10-31 |
| NCT00634673 |
Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) |
https://ClinicalTrials.gov/show/NCT00634673 |
Completed |
Hospital de Clinicas de Porto Alegre |
2007-10-31 |
| NCT00630877 |
Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin |
https://ClinicalTrials.gov/show/NCT00630877 |
Completed |
Abbott |
2008-06-30 |
| NCT00626392 |
Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00626392 |
Completed |
Abbott |
2008-04-30 |
| NCT00625170 |
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans |
https://ClinicalTrials.gov/show/NCT00625170 |
Completed |
Leiden University Medical Center |
2004-12-31 |
| NCT00625014 |
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans |
https://ClinicalTrials.gov/show/NCT00625014 |
Completed |
Leiden University Medical Center |
2005-07-31 |
| NCT00616772 |
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood |
https://ClinicalTrials.gov/show/NCT00616772 |
Completed |
AbbVie |
2012-09-30 |
| NCT00608699 |
A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00608699 |
Completed |
GlaxoSmithKline |
2008-04-30 |
| NCT00607373 |
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00607373 |
Completed |
Kastle Therapeutics, LLC |
2009-03-31 |
| NCT00605787 |
TTA in Treatment of Diabetes and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00605787 |
Completed |
Haukeland University Hospital |
2003-06-30 |
| NCT00593047 |
LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin |
https://ClinicalTrials.gov/show/NCT00593047 |
Completed |
Karo Bio AB |
2008-07-31 |
| NCT00585143 |
Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly |
https://ClinicalTrials.gov/show/NCT00585143 |
Completed |
AstraZeneca |
2008-10-31 |
| NCT00574808 |
Improved Delivery of Cardiovascular Care Through Outreach Facilitation |
https://ClinicalTrials.gov/show/NCT00574808 |
Completed |
Bruyere Research Institute |
2013-02-28 |
| NCT00551694 |
A Second Study to Determine the Effect of GSK256073A on HVTs |
https://ClinicalTrials.gov/show/NCT00551694 |
Completed |
GlaxoSmithKline |
2007-12-31 |
| NCT00542386 |
A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia |
https://ClinicalTrials.gov/show/NCT00542386 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2009-11-30 |
| NCT00540293 |
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study |
https://ClinicalTrials.gov/show/NCT00540293 |
Completed |
Pfizer |
2008-05-31 |
| NCT00535886 |
The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00535886 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
NA |
| NCT00526682 |
The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids |
https://ClinicalTrials.gov/show/NCT00526682 |
Completed |
Gateway Health Alliance |
NA |
| NCT00508937 |
Dietary Protein and Insulin Sensitivity Study |
https://ClinicalTrials.gov/show/NCT00508937 |
Completed |
UCSF Benioff Children’s Hospital Oakland |
2009-11-30 |
| NCT00506961 |
Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00506961 |
Completed |
Taipei Veterans General Hospital, Taiwan |
2007-07-31 |
| NCT00504829 |
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00504829 |
Completed |
Veloxis Pharmaceuticals |
2008-02-29 |
| NCT00493506 |
ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency |
https://ClinicalTrials.gov/show/NCT00493506 |
Completed |
Health Enhancement Products, Inc. |
NA |
| NCT00491530 |
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00491530 |
Completed |
Abbott |
2008-11-30 |
| NCT00490178 |
Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00490178 |
Completed |
Solvay Pharmaceuticals |
NA |
| NCT00488449 |
Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00488449 |
Completed |
GlaxoSmithKline |
2007-11-30 |
| NCT00487994 |
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00487994 |
Completed |
Takeda |
2007-05-31 |
| NCT00486941 |
Lifestyle Intervention in Primary Health Care - the Björknäs Study |
https://ClinicalTrials.gov/show/NCT00486941 |
Completed |
Umeå University |
NA |
| NCT00481364 |
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients |
https://ClinicalTrials.gov/show/NCT00481364 |
Completed |
Ege University |
2008-12-31 |
| NCT00479882 |
MK-0524B Lipid Study (MK-0524B-063) |
https://ClinicalTrials.gov/show/NCT00479882 |
Completed |
Merck Sharp & Dohme Corp. |
2008-06-16 |
| NCT00479388 |
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) |
https://ClinicalTrials.gov/show/NCT00479388 |
Completed |
Merck Sharp & Dohme Corp. |
2008-07-31 |
| NCT00477594 |
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00477594 |
Completed |
Kastle Therapeutics, LLC |
2011-03-31 |
| NCT00477204 |
Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT00477204 |
Completed |
University of Colorado, Denver |
2010-08-31 |
| NCT00474864 |
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. |
https://ClinicalTrials.gov/show/NCT00474864 |
Completed |
GlaxoSmithKline |
2008-04-30 |
| NCT00465088 |
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) |
https://ClinicalTrials.gov/show/NCT00465088 |
Completed |
Abbott |
2008-02-29 |
| NCT00463606 |
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00463606 |
Completed |
AstraZeneca |
2008-02-29 |
| NCT00462046 |
Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00462046 |
Completed |
Shanghai Jiao Tong University School of Medicine |
NA |
| NCT00455403 |
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) |
https://ClinicalTrials.gov/show/NCT00455403 |
Completed |
Washington University School of Medicine |
2009-12-31 |
| NCT00447070 |
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients |
https://ClinicalTrials.gov/show/NCT00447070 |
Completed |
Foundation for Cardiovascular Research, Zurich |
NA |
| NCT00442845 |
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) |
https://ClinicalTrials.gov/show/NCT00442845 |
Completed |
Pfizer |
2004-02-29 |
| NCT00442325 |
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets |
https://ClinicalTrials.gov/show/NCT00442325 |
Completed |
Pfizer |
NA |
| NCT00441480 |
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels |
https://ClinicalTrials.gov/show/NCT00441480 |
Completed |
Enzymotec |
2008-06-30 |
| NCT00422006 |
Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance |
https://ClinicalTrials.gov/show/NCT00422006 |
Completed |
Nantes University Hospital |
2013-11-30 |
| NCT00438061 |
Effect of Abdominal Obesity on Lipoprotein Metabolism |
https://ClinicalTrials.gov/show/NCT00438061 |
Completed |
The University of Western Australia |
NA |
| NCT00422266 |
Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults |
https://ClinicalTrials.gov/show/NCT00422266 |
Completed |
Centre for Chronic Disease Control, India |
NA |
| NCT00412113 |
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk |
https://ClinicalTrials.gov/show/NCT00412113 |
Completed |
Pfizer |
2008-04-30 |
| NCT00409240 |
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT00409240 |
Completed |
Providence VA Medical Center |
2008-06-30 |
| NCT00405197 |
MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study |
https://ClinicalTrials.gov/show/NCT00405197 |
Completed |
Wageningen University |
NA |
| NCT00405171 |
Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00405171 |
Completed |
University Hospital, Caen |
NA |
| NCT00362908 |
Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00362908 |
Completed |
University of Washington |
2009-09-30 |
| NCT00400231 |
The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study |
https://ClinicalTrials.gov/show/NCT00400231 |
Completed |
University of Pennsylvania |
2007-12-31 |
| NCT00392717 |
Regulation of Lipoprotein Metabolism in Obese Men |
https://ClinicalTrials.gov/show/NCT00392717 |
Completed |
The University of Western Australia |
NA |
| NCT00385931 |
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin |
https://ClinicalTrials.gov/show/NCT00385931 |
Completed |
Novartis |
2003-04-30 |
| NCT00385658 |
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00385658 |
Completed |
Novartis |
2007-03-31 |
| NCT00379756 |
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00379756 |
Completed |
GlaxoSmithKline |
2007-05-17 |
| NCT00362323 |
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO |
https://ClinicalTrials.gov/show/NCT00362323 |
Completed |
Solvay Pharmaceuticals |
2008-08-31 |
| NCT00362180 |
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration |
https://ClinicalTrials.gov/show/NCT00362180 |
Completed |
Kastle Therapeutics, LLC |
2010-03-31 |
| NCT00358033 |
Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic |
https://ClinicalTrials.gov/show/NCT00358033 |
Completed |
Providence VA Medical Center |
2008-05-31 |
| NCT00357955 |
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients |
https://ClinicalTrials.gov/show/NCT00357955 |
Completed |
Providence VA Medical Center |
2008-05-31 |
| NCT00350038 |
Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions |
https://ClinicalTrials.gov/show/NCT00350038 |
Completed |
Sanofi |
NA |
| NCT00349128 |
Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes |
https://ClinicalTrials.gov/show/NCT00349128 |
Completed |
Solvay Pharmaceuticals |
NA |
| NCT00348751 |
CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners |
https://ClinicalTrials.gov/show/NCT00348751 |
Completed |
Erasmus Medical Center |
NA |
| NCT00346697 |
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT00346697 |
Completed |
Brown, Todd, M.D., Ph.D. |
2010-04-30 |
| NCT00345657 |
Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care |
https://ClinicalTrials.gov/show/NCT00345657 |
Completed |
In His Image |
NA |
| NCT00345410 |
Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00345410 |
Completed |
Sanofi |
2007-06-30 |
| NCT00344370 |
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00344370 |
Completed |
Kowa Research Europe |
2008-04-30 |
| NCT00344175 |
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors |
https://ClinicalTrials.gov/show/NCT00344175 |
Completed |
Kowa Research Europe |
2007-08-31 |
| NCT00332761 |
Caduet in an Untreated Subject Population |
https://ClinicalTrials.gov/show/NCT00332761 |
Completed |
Pfizer |
NA |
| NCT00331487 |
Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00331487 |
Completed |
Takeda |
2004-03-31 |
| NCT00330876 |
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00330876 |
Completed |
Kowa Research Europe |
2007-12-31 |
| NCT00330785 |
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia |
https://ClinicalTrials.gov/show/NCT00330785 |
Completed |
Pfizer |
NA |
| NCT00327054 |
Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00327054 |
Completed |
Aga Khan University |
NA |
| NCT00326326 |
Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes. |
https://ClinicalTrials.gov/show/NCT00326326 |
Completed |
Pfizer |
NA |
| NCT00325780 |
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00325780 |
Completed |
Kowa Research Europe |
2007-11-30 |
| NCT00316095 |
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00316095 |
Completed |
Boehringer Ingelheim |
2007-08-31 |
| NCT00312923 |
Preliminary Study of Safety and Efficacy of Policosanol |
https://ClinicalTrials.gov/show/NCT00312923 |
Completed |
Rush University Medical Center |
2009-07-31 |
| NCT00309777 |
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin |
https://ClinicalTrials.gov/show/NCT00309777 |
Completed |
Kowa Research Europe |
2006-10-31 |
| NCT00309751 |
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00309751 |
Completed |
Kowa Research Europe |
2007-06-30 |
| NCT00309738 |
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin |
https://ClinicalTrials.gov/show/NCT00309738 |
Completed |
Kowa Research Europe |
2006-10-31 |
| NCT00309712 |
Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study |
https://ClinicalTrials.gov/show/NCT00309712 |
Completed |
Intermountain Health Care, Inc. |
NA |
| NCT00304993 |
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00304993 |
Completed |
Foundation Research, Florida |
NA |
| NCT00300482 |
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood |
https://ClinicalTrials.gov/show/NCT00300482 |
Completed |
Abbott |
2006-12-31 |
| NCT00300469 |
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood |
https://ClinicalTrials.gov/show/NCT00300469 |
Completed |
Abbott |
2007-02-28 |
| NCT00300456 |
Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood |
https://ClinicalTrials.gov/show/NCT00300456 |
Completed |
Abbott |
2007-03-31 |
| NCT00282659 |
The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control |
https://ClinicalTrials.gov/show/NCT00282659 |
Completed |
Hartford Hospital |
2008-06-30 |
| NCT00270439 |
Omentectomy for the Treatment of Diabetes Mellitus Type 2 |
https://ClinicalTrials.gov/show/NCT00270439 |
Completed |
Vanderbilt University |
2007-01-31 |
| NCT00268697 |
Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia. |
https://ClinicalTrials.gov/show/NCT00268697 |
Completed |
Takeda |
2007-01-31 |
| NCT00267254 |
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. |
https://ClinicalTrials.gov/show/NCT00267254 |
Completed |
Pfizer |
NA |
| NCT00264394 |
Cardiovascular Risk Factor Management in HIV Infection |
https://ClinicalTrials.gov/show/NCT00264394 |
Completed |
University Hospital, Basel, Switzerland |
2008-10-31 |
| NCT00257686 |
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients |
https://ClinicalTrials.gov/show/NCT00257686 |
Completed |
Kowa Research Europe |
2006-05-31 |
| NCT00256178 |
Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. |
https://ClinicalTrials.gov/show/NCT00256178 |
Completed |
Takeda |
2007-03-31 |
| NCT00249938 |
Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. |
https://ClinicalTrials.gov/show/NCT00249938 |
Completed |
University of Colorado, Denver |
NA |
| NCT00249249 |
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels |
https://ClinicalTrials.gov/show/NCT00249249 |
Completed |
Kowa Research Europe |
NA |
| NCT00245388 |
Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00245388 |
Completed |
Bristol-Myers Squibb |
NA |
| NCT00240305 |
A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00240305 |
Completed |
AstraZeneca |
NA |
| NCT00240266 |
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTORâ„¢) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT) |
https://ClinicalTrials.gov/show/NCT00240266 |
Completed |
AstraZeneca |
2004-11-30 |
| NCT00239967 |
An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese Patients |
https://ClinicalTrials.gov/show/NCT00239967 |
Completed |
Sanofi |
2007-02-28 |
| NCT00218998 |
Effective Endurance Training in Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00218998 |
Completed |
Norwegian University of Science and Technology |
NA |
| NCT00217061 |
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00217061 |
Completed |
Mayo Clinic |
2005-10-31 |
| NCT00194402 |
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00194402 |
Completed |
University of Washington |
2006-01-31 |
| NCT00192621 |
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects |
https://ClinicalTrials.gov/show/NCT00192621 |
Completed |
Kirby Institute |
2006-12-31 |
| NCT00174304 |
Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. |
https://ClinicalTrials.gov/show/NCT00174304 |
Completed |
Pfizer |
NA |
| NCT00171327 |
Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction |
https://ClinicalTrials.gov/show/NCT00171327 |
Completed |
Novartis |
2005-09-30 |
| NCT00171288 |
Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone |
https://ClinicalTrials.gov/show/NCT00171288 |
Completed |
Novartis |
2005-08-31 |
| NCT00171262 |
Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers |
https://ClinicalTrials.gov/show/NCT00171262 |
Completed |
Novartis |
2007-06-30 |
| NCT00171236 |
Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00171236 |
Completed |
Novartis |
2005-03-31 |
| NCT00169559 |
Dyslipidemia Study Investigating The Increase In “Good Cholesterol” |
https://ClinicalTrials.gov/show/NCT00169559 |
Completed |
GlaxoSmithKline |
2005-04-30 |
| NCT00158899 |
GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol |
https://ClinicalTrials.gov/show/NCT00158899 |
Completed |
GlaxoSmithKline |
2006-06-30 |
| NCT00150384 |
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population |
https://ClinicalTrials.gov/show/NCT00150384 |
Completed |
Pfizer |
NA |
| NCT00143663 |
Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol |
https://ClinicalTrials.gov/show/NCT00143663 |
Completed |
Takeda |
2006-04-30 |
| NCT00136799 |
Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00136799 |
Completed |
Novartis |
2006-04-30 |
| NCT00125125 |
Fluvastatin in Adults With Dislipidemia With History of Muscle Problems |
https://ClinicalTrials.gov/show/NCT00125125 |
Completed |
Novartis |
2005-12-31 |
| NCT00116519 |
A Study in People With Abnormal Fat Levels in the Blood |
https://ClinicalTrials.gov/show/NCT00116519 |
Completed |
Eli Lilly and Company |
NA |
| NCT00111891 |
An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) |
https://ClinicalTrials.gov/show/NCT00111891 |
Completed |
Merck Sharp & Dohme Corp. |
2005-08-31 |
| NCT00109603 |
Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy |
https://ClinicalTrials.gov/show/NCT00109603 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-07-31 |
| NCT00108212 |
Effect of Diet on Men and Women With Genetic Alterations Associated With Abnormal Blood Tests |
https://ClinicalTrials.gov/show/NCT00108212 |
Completed |
VA Office of Research and Development |
NA |
| NCT00082251 |
Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST |
https://ClinicalTrials.gov/show/NCT00082251 |
Completed |
Kos Pharmaceuticals |
NA |
| NCT00080275 |
Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) |
https://ClinicalTrials.gov/show/NCT00080275 |
Completed |
Kos Pharmaceuticals |
NA |
| NCT00079638 |
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL |
https://ClinicalTrials.gov/show/NCT00079638 |
Completed |
Kos Pharmaceuticals |
NA |
| NCT00029835 |
Obese Patients With Untreated Dyslipidemias |
https://ClinicalTrials.gov/show/NCT00029835 |
Completed |
Sanofi |
2003-11-30 |
| NCT00666172 |
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women |
https://ClinicalTrials.gov/show/NCT00666172 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-11-01 |
| NCT00653965 |
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) |
https://ClinicalTrials.gov/show/NCT00653965 |
Completed |
AstraZeneca |
NA |
| NCT00330980 |
Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels |
https://ClinicalTrials.gov/show/NCT00330980 |
Completed |
University of California, San Diego |
2004-03-31 |
| NCT00300430 |
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. |
https://ClinicalTrials.gov/show/NCT00300430 |
Completed |
Abbott |
2008-03-31 |
| NCT00728910 |
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study |
https://ClinicalTrials.gov/show/NCT00728910 |
Completed |
University of Pennsylvania |
2009-08-31 |
| NCT00348725 |
Acceptability of a Fixed Combination of Fenofibrate and Metformin |
https://ClinicalTrials.gov/show/NCT00348725 |
Completed |
Solvay Pharmaceuticals |
NA |
| NCT00455325 |
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) |
https://ClinicalTrials.gov/show/NCT00455325 |
Active, not recruiting |
Washington University School of Medicine |
2020-12-31 |